HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring
|
By IntellAsia: Resources
on 5/3/2021
Companies Initiated Phase I trial in December 2020 TAIPEI, May 4, 2021 /PRNewswire/ -- HCmed today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring t...
Full "IntellAsia: Resources" article
|
|